SABRINA SCARBROUGH: Open Payments
NPI 1528723160 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 18 payments from 9 companies in 2025. Trend: 2023 $112 · 2024 $266 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $144 |
| ViiV Healthcare Company | 3 | $88 |
| Inspire Medical Systems, Inc. | 1 | $46 |
| PFIZER INC. | 2 | $31 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Lilly USA, LLC | 2 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
| ABIOMED | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: DOVATO, INSPIRE, PIFELTRO, MOUNJARO, Veozah, APRETUDE, PENMENVY, NURTEC ODT.
Industry payments across NE — which companies pay providers there.
